Bajaj HealthCare Limited share price
NSE: BAJAJHCARE · ISIN INE411U01027
Key numbers
- Market cap
- ₹ 1,159 Cr
- Current price
- ₹ 344.15
- 52-week high / low
- ₹ 510 / 272
- Stock P/E
- 49.0
- Book value
- ₹ 167.0
- Dividend yield
- 0.44%
- ROCE
- 6.8%
- ROE
- 3.2%
- Debt to equity
- 0.47
- Sales growth (3 yrs)
- -1.8%
- Profit growth (3 yrs)
- -28.4%
- 1-year return
- -32.2%
About Bajaj HealthCare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anthelmintic, anti viral, anti coagulant, vitamin c, anti arthritis, atypical antipsychotic agent, anti convulsant, vasoprotective, disinfectant, anti asthamatic, neuro protective, anti histamine, iron chelator, vasoprotective, urinary tract infection, anti migraine, anti rheumatic, antibiotic, anti tussive, weight reducing, hemorheologic agent, vasodilator, anti psychotic, beta agonist, gastroretentive drug, and antagonist. It also provides 2-amino-3,5-dibromobenzaldehyde, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid and octopamine HCL, 8- chloro theophylline, chlorohexanone, theobromine, hesperidin, 5-amino-2,4,6-triiodoisophthaloyl dichloride, 3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8- bromo xanthine, 8 bromo-3-methyl xanthine, 4,5-dinitroaniline,…
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 154 | 149 | 161 | 153 | 166 |
| Operating profit | 12 | 25 | 31 | 23 | 29 |
| Net profit | 11 | 12 | 16 | -23 | 14 |
| EPS (₹) | 3.54 | 3.74 | 4.96 | -7.16 | 4.07 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.